Phyto Chem (India) Ltd (PHYTO) — shareholding pattern, promoter holding, financials and share price
About Phyto Chem (India) Ltd (PHYTO)
Phyto Chem (India) Ltd operates in the Pesticides & Agrochemicals industry, within the Chemicals sector. It trades on the NSE as PHYTO and on the BSE under scrip code 524808. Its ISIN is INE037C01010.
Incorporated in 1989, Phyto Chem Ltd is in the manufacturing of pesticide formulations and real estate activities [1]
Phyto Chem (India) Ltd specializes in the manufacturing and marketing of pesticides, catering to the agricultural sector across key Indian states.
The company has diversified into real estate activities, marking its presence in Hyderabad and Bangalore, responding to growing demand for housing and infrastructure.
Listed peers in Pesticides & Agrochemicals: Nirman Agri Genetics Ltd, Adarsh Plant Protect Ltd, Continental Seeds and Chemicals Ltd, Natural Biocon (India) Ltd, Shanti Overseas (India) Ltd, PB Global Ltd.
Valuation & Returns
10 Jul 2026At ₹24.49 a share on 10 Jul 2026, Phyto Chem (India) Ltd (PHYTO) was valued at a price-to-earnings ratio of -5.83x against an industry P/E of 22.12x and a price-to-book of 1.65x on a book value of ₹14.85 per share as of Mar 2025. Solomo computes return on equity of -28.18% and return on capital employed of -1.62% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -5.83x
- Industry P/E
- 22.12x
- P/B
- 1.65x
- EPS (TTM)
- ₹-4.19
- Book value / share
- ₹14.85
- ROE
- -28.18%
- ROCE
- -1.62%
- ROA
- -6.45%
- Debt / equity
- 2.47x
- Dividend yield
- 0%
- EBITDA margin
- -0.22%
- 52-week range
- ₹18.53 – ₹34.99
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Phyto Chem (India) Ltd (PHYTO) reported revenue of ₹9.07 crore, net profit of ₹-1.8 crore and earnings per share of ₹-4.19. That compares with revenue of ₹14.08 crore and net profit of ₹-0.99 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹0.23 crore and net profit ₹-0.28 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 23.12 | 26.76 | 14.75 | 14.08 | 9.07 |
| Net profit (₹ cr) | 0.23 | 0.22 | -3.33 | -0.99 | -1.8 |
| EPS (₹) | 0.53 | 0.51 | -7.74 | -2.3 | -4.19 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -6.60% | -23.03% | -15.24% | -4.93% |
| Profit growth | - | - | - | 70.27% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 40.4% of Phyto Chem (India) Ltd (PHYTO) (unchanged from the previous quarter) and domestic institutional investors (DII) hold 0.19%. Market capitalisation was ₹11 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: HUF 1.34%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 40.4% | - | - | 0.19% | 59.6% |
| Mar 2026 | 40.4% | - | - | 0.19% | 59.6% |
| Dec 2025 | 40.4% | - | - | 0.19% | 59.6% |
| Sep 2025 | 40.4% | - | - | 0.19% | 59.6% |
| Jun 2025 | 40.4% | - | - | 0.19% | 59.6% |
| Mar 2025 | 40.4% | - | - | 0.19% | 59.6% |
| Dec 2024 | 40.4% | - | - | 0.19% | 59.6% |
| Sep 2024 | 40.4% | - | - | 0.19% | 59.6% |